Teyi Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate

Latest as of December 2025: 0.45x

Teyi Pharmaceutical Group Co Ltd cash flow reinvestment rate. Teyi Pharmaceutical Group Co Ltd (002728) has a Cash Flow Reinvestment Rate of 0.45x as of December 2025, reinvesting CN¥23.74 Million (capex CN¥23.69 Million plus investments CN¥46.85K) from operating cash flow of CN¥52.94 Million. See 002728 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.45x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥23.74 Million
Capex + Investments

Operating Cash Flow

CN¥52.94 Million
CNY

Capital Expenditures

CN¥23.69 Million
CNY

Cash Flow Reinvestment Rate of Teyi Pharmaceutical Group Co Ltd (2009–2025)

Cash flow reinvestment rate of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. Historical reinvestment intensity for Teyi Pharmaceutical Group Co Ltd across 16 annual periods. Explore Teyi Pharmaceutical Group Co Ltd (002728) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Teyi Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate by Year (2009–2025)

Teyi Pharmaceutical Group Co Ltd cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Teyi Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see Teyi Pharmaceutical Group Co Ltd cash conversion from operations.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 0.33x CN¥80.34 Million CN¥244.88 Million CN¥79.55 Million ▼ -62.0%
2023 0.86x CN¥171.58 Million CN¥198.56 Million CN¥86.05 Million ▲ +65.9%
2022 0.52x CN¥193.60 Million CN¥371.66 Million CN¥90.26 Million ▼ -62.8%
2021 1.40x CN¥359.58 Million CN¥256.81 Million CN¥109.58 Million ▼ -18.2%
2020 1.71x CN¥289.42 Million CN¥168.99 Million CN¥89.42 Million ▼ -34.6%
2019 2.62x CN¥580.79 Million CN¥221.64 Million CN¥130.79 Million ▲ +22.4%
2018 2.14x CN¥402.44 Million CN¥187.97 Million CN¥152.44 Million ▼ -24.2%
2017 2.82x CN¥290.63 Million CN¥102.96 Million CN¥40.63 Million ▲ +17.8%
2016 2.40x CN¥242.71 Million CN¥101.30 Million CN¥170.85 Million ▼ -4.7%
2015 2.51x CN¥173.09 Million CN¥68.87 Million CN¥101.24 Million ▲ +434.2%
2014 0.47x CN¥26.98 Million CN¥57.35 Million CN¥26.98 Million ▼ -24.2%
2013 0.62x CN¥46.05 Million CN¥74.23 Million CN¥46.05 Million ▲ +101.3%
2012 0.31x CN¥32.20 Million CN¥104.50 Million CN¥32.20 Million ▲ +178.6%
2011 0.11x CN¥7.72 Million CN¥69.81 Million CN¥7.72 Million ▲ +57.7%
2010 0.07x CN¥3.29 Million CN¥46.92 Million CN¥3.29 Million ▼ -61.1%
2009 0.18x CN¥4.02 Million CN¥22.32 Million CN¥4.02 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow